FDA approves Lannett's generic dementia drug

The Food and Drug Administration has approved Lannett Co. Inc. ’s application to market memantine hydrochloride tablets for the treatment of dementia. The product is the generic equivalent of Namenda, a medicine developed by Forest Laboratories to treat moderate-to-severe dementia in patients, including those suffering from Alzheimer’s disease. Dr. Reddy’ s Laboratories and Mylan were the first to introduce generic versions of Namenda last year. Teva Pharmaceutical Industries (NYSE: TEVA),…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news